Psych drug maker KemPharm to add jobs if FDA OKs new ADHD treatment
February 05, 2021 at 12:05 PM EST
The company recently completed a series of transactions to alleviate $93.1 million in debt.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|